|
third eye loan
|
1
|
Resverlogix Corp.
|
Mar 06, 2019 11:09PM
|
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 04, 2019 11:04PM
|
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 04, 2019 03:40PM
|
|
Re: MACE Event rate,....
|
3
|
Resverlogix Corp.
|
Mar 01, 2019 05:05PM
|
|
Re: MACE Event rate,....
|
2
|
Resverlogix Corp.
|
Feb 28, 2019 06:33PM
|
|
Re: MACE Event rate,....
|
2
|
Resverlogix Corp.
|
Feb 28, 2019 04:49PM
|
|
Re: MACE Event rate,....
|
3
|
Resverlogix Corp.
|
Feb 28, 2019 02:15PM
|
|
Re: MACE Event rate,....
|
3
|
Resverlogix Corp.
|
Feb 28, 2019 01:50PM
|
|
Re: MACE Event rate,....
|
3
|
Resverlogix Corp.
|
Feb 28, 2019 01:40PM
|
|
Re: MACE Event rate,....
|
4
|
Resverlogix Corp.
|
Feb 28, 2019 12:19PM
|
|
Re: What's going on in Toronto ......
|
2
|
Resverlogix Corp.
|
Feb 25, 2019 03:46PM
|
|
Re: The waiting game.....
|
5
|
Resverlogix Corp.
|
Feb 12, 2019 06:39PM
|
|
Re: The waiting game.....
|
2
|
Resverlogix Corp.
|
Feb 12, 2019 05:09PM
|
|
Re: Contest Tally
|
2
|
Resverlogix Corp.
|
Feb 12, 2019 04:44PM
|
|
Re: Sanofi Resverlogix connection?
|
1
|
Resverlogix Corp.
|
Jan 13, 2019 10:54PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 04:16PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
4
|
Resverlogix Corp.
|
Jan 09, 2019 04:00PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
3
|
Resverlogix Corp.
|
Jan 09, 2019 01:07PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
6
|
Resverlogix Corp.
|
Jan 08, 2019 04:24PM
|
|
RVX-297 vs RVX-208 for autoimmune indications
|
5
|
Resverlogix Corp.
|
Jan 08, 2019 12:18AM
|
